U.S. Markets open in 58 hrs, 38 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 32.982 09:41 AM EDT | |
|---|---|---|
| Day High | 33.68 09:33 AM EDT |
|
| Range | 0.70 |
| Volume | 1.48 M | |
|---|---|---|
| 30-Day Avg Vol | 1.66 M |
|
| Difference | -10.88% |
| Market Cap | 3.49 B | |
|---|---|---|
| Mkt Cap Chg | -78.00 M |
| Shares Out | 105.41 M | |
|---|---|---|
| % Shrs Traded | 1.41% | |
| 1yr EPS Est | 2.47 |
| 52-Wk Low | 20.17 10/10/08 | |
|---|---|---|
| 52-Wk High | 34.25 7/1/09 |
|
| Range | 14.08 |
| Prev Close | 33.92 7/1/09 | |
|---|---|---|
| Today's Open | 33.56 | |
| Change | -1.06% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.12 M |
| Revenue (LFY) | 2.53 B | |
|---|---|---|
| Earnings (LFY) | 238.38 M | |
| Earnings (MRQ) | 49.10 M | |
| Next Earn Est | 0.57 | |
| Next Earnings | 08/07/2009 |
|
| EPS (TTM) | 2.08 | |
| 1yr EPS Growth | 19.90% |
| P/E Ratio (TTM) | 16.03 | |
|---|---|---|
| P/E Ratio (Fwd) | 13.00 | |
| PEG Ratio | 1.34 | |
| Return on Equity | 10.35 | |
| Beta | 0.60 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
CNBC Video
Watson Pharmaceuticals tries to have the best of both worlds, with operations in the US generics market and the higher-profit-margin branded drug business. The company's broad generics portfolio of about ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.57 8/7/09 | — — |
—
—
|
| Last Quarter | 0.492 3/31/09 | 0.58 3/31/09 |
0.088
Beat
|
| 2 Quarters Ago | 0.499 12/31/08 | 0.53 12/31/08 |
0.031
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 667.40 M | 2.54 B |
| Gross Profit | 256.90 M | 980.04 M |
| Operating Income | 80.00 M | 388.88 M |
| Net Income | 49.10 M | 238.38 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts